Literature DB >> 28641878

Diagnosis and Management of Pleural Transudates.

Lucía Ferreiro1, José M Porcel2, Luis Valdés3.   

Abstract

Various clinical trials have been published on the optimal clinical management of patients with pleural exudates, particularly those caused by malignant tumors, while little information is available on the diagnosis and treatment of pleural transudates. The etiology of pleural transudates is wide and heterogeneous, and they can be caused by rare diseases, sometimes constituting a diagnostic challenge. Analysis of the pleural fluid can be a useful procedure for establishing diagnosis. Treatment should target not only the underlying disease, but also management of the pleural effusion itself. In cases refractory to medical treatment, invasive procedures will be necessary, for example therapeutic thoracentesis, pleurodesis with talc, or insertion of an indwelling pleural catheter. Little evidence is currently available and no firm recommendations have been made to establish when to perform an invasive procedure, or to determine the safest, most efficient approach in each case. This article aims to describe the spectrum of diseases that cause pleural transudate, to review the diagnostic contribution of pleural fluid analysis, and to highlight the lack of evidence on the efficacy of invasive procedures in the management and control of pleural effusion in these patients.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Catéter pleural tunelizado; Derrame pleural; Heart failure; Hepatic hydrothorax; Hidrotórax hepático; Indwelling pleural catheter; Insuficiencia cardiaca; Líquido pleural; Pleural effusion; Pleural fluid; Pleurodesis; Pulmón atrapado; Transudates; Trapped lung; Trasudados

Mesh:

Substances:

Year:  2017        PMID: 28641878     DOI: 10.1016/j.arbres.2017.04.018

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  4 in total

1.  Clinical characteristics and prognosis of serous body cavity effusions in patients with sepsis: a retrospective observational study.

Authors:  Ling-Yu Xing; Jun Yin; Mian Shao; Yi-Lin Yang; Ke-Yong Li; Ming-Ming Xue; Su-Cheng Mu; Zhan Sun; Ya-Ping Zhang; Chen-Ling Yao; Xun Chu; Chao-Yang Tong; Zhen-Ju Song
Journal:  BMC Anesthesiol       Date:  2018-11-14       Impact factor: 2.217

2.  Percutaneous Ultrasound-guided Pigtail Catheter for Pleural Effusions: Efficacy and Safety.

Authors:  B Jayakrishnan; Masoud Kashoob; Rashid Al-Sukaiti; Saif Al-Mubaihsi; Anupam Kakaria; Amal Al-Ghafri; Yasser Al-Lawati
Journal:  Oman Med J       Date:  2021-03-31

3.  Value of ultrasonography in determining the nature of pleural effusion: Analysis of 582 cases.

Authors:  Ting Wang; Ge Du; Liping Fang; Yang Bai; Zishuang Liu; Li Wang
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

Review 4.  Biomarkers in the diagnosis of pleural diseases: a 2018 update.

Authors:  José M Porcel
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.